微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.35% | -40.79% | 381.25% | 93/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.48% | -190.57% | -190.57% | 107/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.53% | -53.91% | 127.89% | 87/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -1.9% | -102.2% | -183.33% | 105/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 2.28% | -97.26% | 330.19% | 93/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.53% | -99.2% | -53.91% | 103/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.15% | -97.11% | -98.67% | 78/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 86.31% | 12.82% | 3.78% | 2/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 83.17% | 31.25% | 26.09% | 2/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 65.96% | 61.15% | 65.6% | 3/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 39.83% | 49.29% | -47.93% | 3/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 76.5% | 41.25% | 20.72% | 4/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 63.37% | 39.61% | 54.83% | 4/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 40.93% | 44.42% | 53.41% | 6/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 26.68% | 8237.5% | -50.74% | 5/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 54.16% | 983.2% | 19.32% | 18/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 45.39% | 510.08% | 60.16% | 11/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 28.34% | 428.73% | 8756.25% | 17/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.32% | -88.15% | -93.6% | 66/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 5% | -60.16% | -32.8% | 97/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 7.44% | -48.23% | 38.81% | 42/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.36% | -63.14% | 98.52% | 42/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.7% | -51% | -78.49% | 23/129 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 12.55% | -55.96% | -12.67% | 58/129 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 14.37% | 2% | -1.17% | 11/129 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 14.54% | -18.13% | 163.88% | 1/129 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 5.51% | 2% | -80.67% | 5/129 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 28.5% | -28.05% | 60.47% | 17/129 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-06-30 | 17.76% | -23.74% | -55.16% | 3/129 | 5.9% | 大博医疗 | 30.55% | 行业排名> |
| 2016-12-31 | 39.61% | -17.91% | 70.07% | 5/129 | 16.21% | 基蛋生物 | 23.11% | 行业排名> |
| 2016-06-30 | 23.29% | -22.19% | -51.73% | 1/129 | 6.26% | 基蛋生物 | 11.34% | 行业排名> |
| 2015-12-31 | 48.25% | -32.39% | 61.21% | 2/129 | 15.95% | 奥泰生物 | 76.87% | 行业排名> |
| 2015-06-30 | 29.93% | -23.75% | -58.06% | 1/129 | 7.77% | 安图生物 | 28% | 行业排名> |